Tenon Medical Inc
NASDAQ:TNON

Watchlist Manager
Tenon Medical Inc Logo
Tenon Medical Inc
NASDAQ:TNON
Watchlist
Price: 0.7656 USD 0.51% Market Closed
Market Cap: $8.7m

Tenon Medical Inc
Gross Profit

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Tenon Medical Inc
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Tenon Medical Inc
NASDAQ:TNON
Gross Profit
$2.4m
CAGR 3-Years
N/A
CAGR 5-Years
139%
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Gross Profit
$14.2B
CAGR 3-Years
16%
CAGR 5-Years
17%
CAGR 10-Years
10%
Edwards Lifesciences Corp
NYSE:EW
Gross Profit
$4.9B
CAGR 3-Years
4%
CAGR 5-Years
8%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Gross Profit
$16.2B
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Gross Profit
$25.5B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Gross Profit
$6.6B
CAGR 3-Years
17%
CAGR 5-Years
18%
CAGR 10-Years
15%
No Stocks Found

Tenon Medical Inc
Glance View

Market Cap
8.7m USD
Industry
Health Care

Tenon Medical Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Los Gatos, California and currently employs 10 full-time employees. The company went IPO on 2022-04-27. Tenon Medical, Inc. is a medical device company. The firm has developed a proprietary surgical implant system, The CATAMARAN SIJ Fusion System (The CATAMARAN System), which is designed to fuse one or both sacroiliac joints (SI-Joint) to treat SI-Joint dysfunction that often causes severe lower back pain. The CATAMARAN System offers a new surgical solution that places a single implant directly into the SI joint, bridging the sacrum and ilium with a posterior inferior surgical approach. The CATAMARAN System includes instruments and implants designed to prepare and fixate the SI-Joint for fusion. The CATAMARAN System is designed specially to resist vertical shear and rotation of the joint in which it was implanted, helping stabilize the joint in preparation for eventual fusion. The company also has developed a proprietary two-dimensional (2D) placement protocol as well as a protocol for three-dimensional (3D) navigation utilizing the latest techniques in spine surgery.

TNON Intrinsic Value
3.4078 USD
Undervaluation 78%
Intrinsic Value
Price $0.7656

See Also

What is Tenon Medical Inc's Gross Profit?
Gross Profit
2.4m USD

Based on the financial report for Dec 31, 2025, Tenon Medical Inc's Gross Profit amounts to 2.4m USD.

What is Tenon Medical Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
139%

Over the last year, the Gross Profit growth was 38%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett